APO RESEARCH · REPORT
Anti-inflammatory Therapeutics
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Product & engineering
Understand the product.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Selected research
Industry Growth & Trends
Global Anti-inflammatory Therapeutics Industry Growth and Trends Forecast to 2032
Market perspective
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
According to APO Research, the global Anti-inflammatory Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Anti-inflammatory Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Anti-inflammatory Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-inflammatory Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-inflammatory Therapeutics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Anti-inflammatory Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Anti-inflammatory Therapeutics Market by Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Anti-inflammatory Therapeutics Segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Anti-inflammatory Therapeutics Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Anti-inflammatory Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Anti-inflammatory Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-inflammatory Biologics
- Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
- Others
Applications
- Arthritis
- Respiratory Diseases
- Dermatology
- Gastroenterology
- Others
Companies covered
- AbbVie
- Johnson & Johnson
- Amgen Inc
- AstraZeneca PLC
- Pfizer, Inc
- Novartis
- Roche
- Merck
- Sanofi
- GlaxoSmithKline
- Sun Pharmaceutical Industries Ltd
- TEVA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Anti-inflammatory Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Anti-inflammatory Therapeutics Market Size by Region (2021-2032)
- 1.4.1 Global Anti-inflammatory Therapeutics Market Size by Region (2021-2026)
- 1.4.2 Global Anti-inflammatory Therapeutics Market Size by Region (2027-2032)
- 1.5 Key Regions Anti-inflammatory Therapeutics Market Size (2021-2032)
- 1.5.1 North America Anti-inflammatory Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Anti-inflammatory Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Anti-inflammatory Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth Rate (2021-2032)
2 Anti-inflammatory Therapeutics Market by Type
- 2.1 Type Introduction
- 2.1.1 Anti-inflammatory Biologics
- 2.1.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- 2.1.3 Corticosteroids
- 2.1.4 Others
- 2.2 Global Anti-inflammatory Therapeutics Market Size by Type
- 2.2.1 Global Anti-inflammatory Therapeutics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Anti-inflammatory Therapeutics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Anti-inflammatory Therapeutics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Anti-inflammatory Therapeutics Market Size by Regions
- 2.3.1 North America Anti-inflammatory Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Anti-inflammatory Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Anti-inflammatory Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Anti-inflammatory Therapeutics Market Size Breakdown by Type (2021-2026)
3 Anti-inflammatory Therapeutics Market by Application
- 3.1 Type Introduction
- 3.1.1 Arthritis
- 3.1.2 Respiratory Diseases
- 3.1.3 Dermatology
- 3.1.4 Gastroenterology
- 3.1.5 Others
- 3.2 Global Anti-inflammatory Therapeutics Market Size by Application
- 3.2.1 Global Anti-inflammatory Therapeutics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Anti-inflammatory Therapeutics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Anti-inflammatory Therapeutics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Anti-inflammatory Therapeutics Market Size by Regions
- 3.3.1 North America Anti-inflammatory Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Anti-inflammatory Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Anti-inflammatory Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Anti-inflammatory Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Anti-inflammatory Therapeutics Industry Trends
- 4.2 Anti-inflammatory Therapeutics Industry Drivers
- 4.3 Anti-inflammatory Therapeutics Industry Opportunities and Challenges
- 4.4 Anti-inflammatory Therapeutics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Anti-inflammatory Therapeutics Revenue (2021-2026)
- 5.2 Global Anti-inflammatory Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Anti-inflammatory Therapeutics Key Company Headquarters & Area Served
- 5.4 Global Anti-inflammatory Therapeutics Company, Product Type & Application
- 5.5 Global Anti-inflammatory Therapeutics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Anti-inflammatory Therapeutics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Anti-inflammatory Therapeutics Players Market Share by Revenue in 2025
- 5.6.3 2025 Anti-inflammatory Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AbbVie
- 6.1.1 AbbVie Company Information
- 6.1.2 AbbVie Business Overview
- 6.1.3 AbbVie Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AbbVie Anti-inflammatory Therapeutics Product Portfolio
- 6.1.5 AbbVie Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Amgen Inc
- 6.3.1 Amgen Inc Company Information
- 6.3.2 Amgen Inc Business Overview
- 6.3.3 Amgen Inc Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Amgen Inc Anti-inflammatory Therapeutics Product Portfolio
- 6.3.5 Amgen Inc Recent Developments
- 6.4 AstraZeneca PLC
- 6.4.1 AstraZeneca PLC Company Information
- 6.4.2 AstraZeneca PLC Business Overview
- 6.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio
- 6.4.5 AstraZeneca PLC Recent Developments
- 6.5 Pfizer, Inc
- 6.5.1 Pfizer, Inc Company Information
- 6.5.2 Pfizer, Inc Business Overview
- 6.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio
- 6.5.5 Pfizer, Inc Recent Developments
- 6.6 Novartis
- 6.6.1 Novartis Company Information
- 6.6.2 Novartis Business Overview
- 6.6.3 Novartis Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Novartis Anti-inflammatory Therapeutics Product Portfolio
- 6.6.5 Novartis Recent Developments
- 6.7 Roche
- 6.7.1 Roche Company Information
- 6.7.2 Roche Business Overview
- 6.7.3 Roche Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Roche Anti-inflammatory Therapeutics Product Portfolio
- 6.7.5 Roche Recent Developments
- 6.8 Merck
- 6.8.1 Merck Company Information
- 6.8.2 Merck Business Overview
- 6.8.3 Merck Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Merck Anti-inflammatory Therapeutics Product Portfolio
- 6.8.5 Merck Recent Developments
- 6.9 Sanofi
- 6.9.1 Sanofi Company Information
- 6.9.2 Sanofi Business Overview
- 6.9.3 Sanofi Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Sanofi Anti-inflammatory Therapeutics Product Portfolio
- 6.9.5 Sanofi Recent Developments
- 6.10 GlaxoSmithKline
- 6.10.1 GlaxoSmithKline Company Information
- 6.10.2 GlaxoSmithKline Business Overview
- 6.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio
- 6.10.5 GlaxoSmithKline Recent Developments
- 6.11 Sun Pharmaceutical Industries Ltd
- 6.11.1 Sun Pharmaceutical Industries Ltd Company Information
- 6.11.2 Sun Pharmaceutical Industries Ltd Business Overview
- 6.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio
- 6.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
- 6.12 TEVA
- 6.12.1 TEVA Company Information
- 6.12.2 TEVA Business Overview
- 6.12.3 TEVA Anti-inflammatory Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 TEVA Anti-inflammatory Therapeutics Product Portfolio
- 6.12.5 TEVA Recent Developments
7 North America
- 7.1 North America Anti-inflammatory Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 7.3 North America Anti-inflammatory Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Anti-inflammatory Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 8.3 Europe Anti-inflammatory Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Anti-inflammatory Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 10.3 South America Anti-inflammatory Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst